MF

Melissa Fleury

TI Theravance Biopharma R&D Ip: 6 patents #1 of 46Top 3%
TC Theravance Respiratory Company: 2 patents #1 of 8Top 15%
📍 Brisbane, CA: #2 of 49 inventorsTop 5%
🗺 California: #2,039 of 68,989 inventorsTop 3%
Overall (2020): #13,769 of 565,922Top 3%
8
Patents 2020

Issued Patents 2020

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
10836744 Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity Adam D. Hughes, Daniel H. Byun, Yan Chen, John R. Jacobsen, Eric L. Stangeland +2 more 2020-11-17
10829438 Neprilysin inhibitors Adam D. Hughes 2020-11-10
10752599 Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof Adam D. Hughes, Miroslav Rapta, Venkat R. Thalladi, Gene Timothy Fass, Michael Simeone 2020-08-25
10744104 Neprilysin inhibitors Adam D. Hughes, Erik Fenster, Roland Gendron, Edmund J. Moran 2020-08-18
10590107 Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activity Adam D. Hughes, Daniel H. Byun, Yan Chen, John R. Jacobsen, Eric L. Stangeland +2 more 2020-03-17
10570120 Neprilysin inhibitors Adam D. Hughes 2020-02-25
10548879 (2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid Adam D. Hughes, Anne-Marie Beausoleil, Erik Fenster, Venkat R. Thalladi, Miroslav Rapta 2020-02-04
10526330 JAK kinase inhibitor compounds for treatment of respiratory disease Paul R. Fatheree, John R. Jacobsen, Gary E. L. Brandt, Lan Jiang, Cameron Smith +3 more 2020-01-07